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After Primary PCI for STEMI*Frederic S. Resnic, MD, Sachin P. Shah, MDSEE PAGE 1161N early 250,000 patients have an ST-segmentelevation myocardial infarction (STEMI)each year in the United States, and this con-
dition results in an estimated 1 million hospital days
and more than $6 billion in hospital-related costs
(1,2). Reducing length of hospital stay (LOS) in this
population, while maintaining quality and outcomes,
would likely result in dramatic cost savings for the
U.S. health care system. Success in the management
of STEMI over the past several decades, in conjunc-
tion with early mobilization of patients, has led to a
steady decrease in the LOS (3,4), which has paralleled
a dramatic decline in overall mortality after STEMI
(5,6). Opportunities to decrease LOS further have
been suggested by geographic variation in LOS after
STEMI (7,8). Although there is ever-growing ﬁnancial
pressure to shorten hospitalization, a lurking concern
is that goals for hospital efﬁciency may outpace med-
ical evidence and may place patients at risk for harm
from hospitalization that is too short after STEMI. The
evidence available to answer the question of the
optimal LOS after primary percutaneous coronary
intervention (PCI) for STEMI is incomplete. This is re-
ﬂected in professional society recommendations that
do not provide clear guidance on the topic (9,10).
Nonrandomized data suggest that an early dis-
charge strategy in low-risk patients is safe (11,12), but
randomized trials investigating the safety of early
discharge are small and signiﬁcantly underpowered
(13–15). The largest of these trials had a statistical*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
From the Department of Cardiovascular Medicine, Lahey Hospital and
Medical Center, Burlington, Massachusetts. Dr. Resnic is a consultant for
St. Jude Medical. Dr. Shah has reported that he has no relationships
relevant to the contents of this paper to disclose.power of <20% to detect a difference in cardiovas-
cular events by 6 months (14). PAMI-II (Primary
Angioplasty in Myocardial Infarction II) randomized
471 low-risk patients to an early discharge or usual
care (mean 4.7 days vs. 7.1 days, respectively) and
found no difference in mortality or adverse clinical
events (14). In a smaller trial, Prague-5 randomized 56
low-risk patients to either a next-day discharge
strategy (n ¼ 37, mean duration of hospitalization
29 h) or usual care (n ¼ 19, mean duration of hospi-
talization 105 h) and found no serious complications
by 30 days (15). Notably, more than 2,000 patients
were screened for this study, but only 3.6% met the
strict inclusion criteria.In this issue of the Journal, Swaminathan et al. (16)
provide supportive evidence that a short hospitali-
zation (#3 days) after primary PCI for STEMI is safe.
Data from more than 33,000 patients from the Na-
tional Cardiovascular Data Registry (NCDR) CathPCI
Registry from 2004 to 2009 were linked to U.S. Center
for Medicare & Medicaid Services (CMS) claims;
therefore, only patients 65 years old or older were
included. Patients’ characteristics and 30-day out-
comes were stratiﬁed by LOS. Of particular impor-
tance, rather than using the more traditionally
accepted “number of midnights” to deﬁne LOS, these
investigators use the CMS deﬁnition. CMS calculates
LOS as the discharge date minus the admission date
plus 1; therefore, a patient admitted on a Monday and
discharged on a Wednesday would be considered to
have an LOS of 3 days as deﬁned by the CMS, but the
same patient would have an LOS of 2 days (2 mid-
nights) using the more conventional deﬁnition.
Swaminathan et al. (16) observed that patients
with a long LOS (>5 days) were older, had more
comorbidities, and were more likely to have
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1173multivessel coronary disease or cardiogenic shock
compared with patients with a medium (4 to 5 days)
or short (#3 days) LOS. Compared with a short LOS,
patients with a long LOS had a higher 30-day mor-
tality rate (unadjusted 0.9% vs. 3.5%, respectively).
These ﬁndings are not unexpected. Differences in
baseline characteristics or differences in the severity
of and complications related to myocardial infarction
are likely to have driven the major adverse cardio-
vascular event (MACE) and mortality rates, as well as
the LOS. These investigators attempted to adjust for
differences in severity of illness and comorbidities,
but undoubtedly unmeasured confounders exist. The
principal ﬁnding of this observational study, even
with the limitations noted, was that there appeared to
be no difference in 30-day mortality and MACE be-
tween patients with a short (#3 days) LOS and pa-
tients with a medium (4 to 5 days) LOS.
An additional important ﬁnding is the signiﬁcant
geographic and hospital-related variation that
seemed to affect LOS. Smaller hospitals and those in
the West and Midwest regions of the United States
were much more likely to have a short LOS. Specif-
ically, 35% of patients in the West compared with
only 16% of patients in the Northeast had a short
LOS. This variation in practice may provide an
opportunity for a substantial reduction in resource
utilization at those hospitals and regions with a
generally longer LOS after primary PCI for STEMI.
Although clinical outcomes and quality must be
carefully monitored with such change in practice, the
adjusted analysis by Swaminathan et al. (16) indicates
that such outcomes can be achieved with a shorter
LOS.
In a secondary analysis, these investigators
examine the mortality rates in a small subset of pa-
tients who were hospitalized for 1 to 2 days(representing patients with a same-day or next-day
discharge). These 1,244 patients had a 30-day mor-
tality rate twice that of patients discharged after 3 to
4 days of hospitalization. These results are intriguing,
but they may simply highlight the limitations of the
dataset analyzed. This group of patients represents
only 3.7% of the entire study population. In addition,
just as confounders such as comorbidities and
severity of illness are likely to affect mortality in pa-
tients with a very long LOS, certain confounders may
also play a role in patients with a very short LOS.
Patients leaving against medical advice or patients
transferred to another health care facility (potentially
as a result of clinical instability) comprise potential
factors that may increase the risk proﬁle of the cohort
with a very short LOS. These limitations signiﬁcantly
affect the ability to make any conclusions about this
small subset of patients discharged after a very short
LOS.
Unfortunately, the lack of a large randomized trial
assessing the safety of an early discharge after pri-
mary PCI for STEMI leaves clinicians with incomplete
evidence with which to make decisions. The paper
by Swaminathan et al. (16) helps afﬁrm that the
current practice to discharge lower-risk patients
early (#3 days) is likely as safe as longer hospital
stays. Given the observed geographic variation, there
is probably an opportunity to apply this practice
more broadly, thereby achieving signiﬁcant health
care cost savings while maintaining the quality of
STEMI care.
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